Transaction · 0001739410-25-000012

Lieber Jonathan I

Lieber Jonathan I, CFO, reported a transaction classified as grant at Rallybio Corp involving 180000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 180000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACFO
RLYBRallybio Corp
Filing timeFeb 20
Trade dateFeb 14, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

RLYB price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RLYB since 2025-02-20Filed 560 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001739410-25-000012
Option (Right to Buy)
Transaction date
Feb 14, 2025
Filed Feb 20, 2025, 12:27 AM · 6d delay
Shares
180k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
180k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 6 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Derivative Transaction Direct Ownership Large Holdings Increase
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 14, 2029.

Original filing · 0001739410-25-000012
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RLYB